ARTHRITIS R&D and SOFREMIP are very pleased to announce that "Subvention ARTHRITIS pour l’émergence de projets 2021" is open:

ARTHRITIS is funded by donors concerned by Rheumatic and Musculoskeletal Diseases (RMDs) and supported by Clarins. The Fondation’s goal is to discover new treatment and diagnostic solutions against RMDs. The Fondation amplifies and accelerates scientific innovation in the area of joint disease (genomics, proteomics, biomarkers, immunology, biotherapies,...). For 30 years, the Fondation funded 11M€ of research on 550 scientific projects, generating 350 publications. The Fondation originally supported the discovery of a diagnostic test of rheumatoid arthritis, now used worldwide as an official diagnostic criteria.

ARTHRITIS R&D, company founded in 2014 as a full-subsidiary of Fondation ARTHRITIS, develops research programs on RMDs in collaboration with academic laboratories, with a potential of application on the market through pharmaceutical partnerships.

Before starting the submission, please carefully read the Presentation, the Guidelines and the structure of the Scientific Part for Application for the Research Grant and Scientific report

Submission deadline is September, 8th 2021, NOON

For any further information about this Call for Proposals, please contact Yosra Messai: / Tel: +33 (0)1 56 60 68 37

Already registered ?